Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4+CD25high regulatory T cells in kidney transplantation
- 30 April 2008
- journal article
- research article
- Published by Elsevier BV in Transplant Immunology
- Vol. 19 (1), 69-73
- https://doi.org/10.1016/j.trim.2008.01.005
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantationTransplant Immunology, 2007
- CD4+ CD25bright+ Regulatory T Cells Can Mediate Donor Nonreactivity in Long-Term Immunosuppressed Kidney Allograft PatientsAmerican Journal of Transplantation, 2006
- Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host diseaseBlood, 2005
- Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-selfNature Immunology, 2005
- Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials1Transplantation, 2004
- Randomised trial of simulect versus placebo for control of acute rejection in renal allograft recipientsTransplantation Proceedings, 2003
- The effect of anti-CD25 monoclonal antibody (Simulect) to the lymphocytes in the peripheral blood of the recipients of kidney transplantationTransplantation Proceedings, 2003
- CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2Rβ-Deficient Mice: Implications for the Nonredundant Function of IL-2Immunity, 2002
- CD4+CD25high Regulatory Cells in Human Peripheral BloodThe Journal of Immunology, 2001
- Ulcerative colitis-like disease in mice with a disrupted interleukin-2 geneCell, 1993